Cognitive Remediation with D-cycloserine to Improve Smoking Cessation Outcomes
Cognitive Remediation with D-cycloserine to Improve Smoking Cessation Outcomes
批准号:
8144483
负责人:
A EDEN EVINS
金额:
$19.02万
依托单位国家:
美国
项目类别:
财政年份:
2010
资助国家:
美国
项目状态:
已结题
起止时间:
2010-09-30 至 2013-05-31
关键词:
AbstinenceAccountingAcuteAgonistAmericanAnimal ModelAnimalsAntibioticsAnxiety DisordersAttenuatedBackBasic ScienceBehavior TherapyBehavioralCardiovascular systemCenters for Disease Control and Prevention (U.S.)Cessation of lifeClinical TrialsClinical Trials DesignCocaineCognitive remediationCotinineCuesCycloserineDataDependenceDoseDouble-Blind MethodDrug AddictionEventExposure toExtinction (Psychology)FDA approvedFaceFrightGalvanic Skin ResponseGlutamate ReceptorGlycineGoalsHandHealth BenefitHeart RateHumanLearningMaintenanceMeasurementMemoryMethodsModelingMorbidity - disease rateN-Methyl-D-Aspartate ReceptorsN-MethylaspartateNicotineOutcomeOutcome AssessmentOutcome MeasureParticipantPatient Self-ReportPharmacotherapyPhysiologicalPlacebo ControlPlacebosPrevention strategyRandomizedRelapseSalivaSiteSmokeSmokerSmokingTherapeutic InterventionTimeTobaccoTobacco DependenceTobacco smokingUnited StatesVisitWithholding Treatmentaddictionbasecost effectivecravingcue reactivitydisorder later incidence preventioneffective therapyfollow-upimprovedlearning extinctionmortalityneurobiological mechanismnon-smokernovelnovel strategiesopen labelpreferencepreventprimary outcomepublic health prioritiesresponsesmoking cessationsuccesstobacco abstinencetreatment effect
中文摘要
点击翻译按钮获取中文摘要
英文摘要
ABSTRACT
One in five Americans smoke tobacco. Each year over 440,000 people in the US and 5 million worldwide die
from smoking-related illness, and the global mortality toll is rising. Pharmacotherapy for smoking cessation is
highly cost effective, but relapse rates are high, and fewer than 20% who attempt cessation are successful on
a given attempt. After completion of smoking cessation treatment, recently abstinent smokers face repeated
environmental cues that often trigger relapse. Cue exposure therapies are directed at reducing cravings in
response to such cues, but these strategies have had only limited efficacy to date. Now, a novel strategy for
strengthening the efficacy of cue exposure approaches is at hand. Basic research has identified d-cycloserine
(DCS), a partial agonist of the NMDA receptor, as an agent capable of enhancing extinction learning.
Following success in animal models, DCS was first applied to the enhancement of extinction learning for the
treatment of acrophobia. Ongoing study has further supported the efficacy of single-dose applications of DCS
to enhance the efficacy of exposure based treatments across the anxiety disorders, presumably by enhancing
the memory of successful exposure sessions. There is also encouraging evidence for the similar segmentation
of extinction based learning in cue exposure models of drug addiction. In this application, we propose to study
DCS enhancement for cue exposure as applied as a relapse prevention strategy for smoking cessation.
Specifically, we propose to assess the effects of two sessions of single dose DCS combined with cue-exposure
treatment (CET) conducted one week apart in a randomized, double-blind, placebo-controlled, parallel group
design trial. This treatment will be offered as a relapse-prevention strategy for smokers who are abstinent upon
completing a standard open label 7-week smoking cessation treatment offered in our center. Outcomes will be
acute changes in cue-reactivity and craving at a Post-Extinction Assessment conducted 2 days after the
second CET session and maintenance of abstinence over a 6-week follow-up period. Accordingly, the
proposed study has the potential of supporting for a novel cognitive remediation strategy to enhance the
efficacy of cue exposure treatments for the maintenance of smoking cessation.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Research Supplement to Promote Diversity in Health-Related Research: Randomized controlled trial of varenicline for cessation of nicotine vaping in adolescent non-smokers
-
批准号:10878366
-
项目类别:
-
资助金额:$6.25万
-
财政年份:2021
-
负责人:A EDEN EVINS
-
依托单位:
Medical Marijuana, Pain, and Opioid Use in Patients with Chronic Non-cancer Pain
-
批准号:10641911
-
项目类别:
-
资助金额:$81.35万
-
财政年份:2021
-
负责人:A EDEN EVINS
-
依托单位:
Medical Marijuana, Pain, and Opioid Use in Patients with Chronic Non-cancer Pain
-
批准号:10211907
-
项目类别:
-
资助金额:$78.52万
-
财政年份:2021
-
负责人:A EDEN EVINS
-
依托单位:
Randomized controlled trial of varenicline for cessation of nicotine vaping in adolescent non-smokers
-
批准号:10689064
-
项目类别:
-
资助金额:$66.48万
-
财政年份:2021
-
负责人:A EDEN EVINS
-
依托单位:
Medical Marijuana, Pain, and Opioid Use in Patients with Chronic Non-cancer Pain
-
批准号:10491683
-
项目类别:
-
资助金额:$81.74万
-
财政年份:2021
-
负责人:A EDEN EVINS
-
依托单位:
Randomized controlled trial of varenicline for cessation of nicotine vaping in adolescent non-smokers
-
批准号:10298337
-
项目类别:
-
资助金额:$66.96万
-
财政年份:2021
-
负责人:A EDEN EVINS
-
依托单位:
Administrative Supplement: Randomized controlled trial of varenicline for cessation of nicotine vaping in adolescent non-smokers
-
批准号:10878378
-
项目类别:
-
资助金额:$16.62万
-
财政年份:2021
-
负责人:A EDEN EVINS
-
依托单位:
Advancing a novel portable detection method for cannabis intoxication
-
批准号:10145857
-
项目类别:
-
资助金额:$39.6万
-
财政年份:2017
-
负责人:A EDEN EVINS
-
依托单位:
Career Development Program in Substance Use and Addiction Medicine
-
批准号:10215450
-
项目类别:
-
资助金额:$53.82万
-
财政年份:2017
-
负责人:A EDEN EVINS
-
依托单位:
Career Development Program in Substance Use and Addiction Medicine
-
批准号:10675872
-
项目类别:
-
资助金额:$53.35万
-
财政年份:2017
-
负责人:A EDEN EVINS
-
依托单位:
Advancing a novel portable detection method for cannabis intoxication
-
批准号:9751264
-
项目类别:
-
资助金额:$33.57万
-
财政年份:2017
-
负责人:A EDEN EVINS
-
依托单位:
Enhancing Self-Control of Cigarette Craving with Real-Time fMRI
-
批准号:8191696
-
项目类别:
-
资助金额:$27.74万
-
财政年份:2011
-
负责人:A EDEN EVINS
-
依托单位:
Enhancing Self-Control of Cigarette Craving with Real-Time fMRI
-
批准号:8299499
-
项目类别:
-
资助金额:$21.37万
-
财政年份:2011
-
负责人:A EDEN EVINS
-
依托单位:
Proof-of-Concept Trial of an Alpha-7 Nicotinic Agonist for Nicotine Dependence
-
批准号:8247694
-
项目类别:
-
资助金额:$121.59万
-
财政年份:2011
-
负责人:A EDEN EVINS
-
依托单位:
Proof-of-Concept Trial of an Alpha-7 Nicotinic Agonist for Nicotine Dependence
-
批准号:8069075
-
项目类别:
-
资助金额:$127.74万
-
财政年份:2011
-
负责人:A EDEN EVINS
-
依托单位:
Proof-of-Concept Trial of an Alpha-7 Nicotinic Agonist for Nicotine Dependence
-
批准号:8507189
-
项目类别:
-
资助金额:$113.16万
-
财政年份:2011
-
负责人:A EDEN EVINS
-
依托单位:
Mentoring in Addiction Treatment Research
-
批准号:8027613
-
项目类别:
-
资助金额:$20.02万
-
财政年份:2010
-
负责人:A EDEN EVINS
-
依托单位:
Mentoring in Addiction Treatment Research
-
批准号:9547357
-
项目类别:
-
资助金额:$18.86万
-
财政年份:2010
-
负责人:A EDEN EVINS
-
依托单位:
Cognitive Remediation with D-cycloserine to Improve Smoking Cessation Outcomes
-
批准号:8059358
-
项目类别:
-
资助金额:$24.69万
-
财政年份:2010
-
负责人:A EDEN EVINS
-
依托单位:
Mentoring in Addiction Treatment Research
-
批准号:9750064
-
项目类别:
-
资助金额:$18.86万
-
财政年份:2010
-
负责人:A EDEN EVINS
-
依托单位:
海外基金